• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    3.32 Down 0.08(2.35%) 4:00PM EST
    |After Hours : 3.32 0.00 (0.00%) 4:05PM EST
    Prev Close:3.40
    Open:3.25
    Bid:3.27 x 3000
    Ask:7.50 x 600
    1y Target Est:7.30
    Beta:2.90119
    Earnings Date:Mar 7 - Mar 11 (Est.)
    Day's Range:3.25 - 3.44
    52wk Range:2.59 - 9.32
    Volume:473,078
    Avg Vol (3m):512,253
    Market Cap:147.56M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXDown 2.35%147.56M
    BAXDown 2.79%19.63B
    CFN 0.00%12.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.42
    Quarterly EPS Est (Dec-15) :-0.10
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company’s lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handhe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback